MedTrace Pharma announced today that it has raised €18.2 million (roughly $19 million) to fund the completion of its Phase 3 trial of its tech to make PET with oxygen-15 labeled water widely available. 15 O-water has a reputation as a gold-standard radioactive tracer for PET imaging, but supply chain problems around the substance have hindered […]
MedTrace Pharma
MedTrace secures U.S. patent for new heart diagnostics software
MedTrace Pharma has secured a U.S. patent for a software algorithm that will play an important role in its efforts to make PET with oxygen-15 labeled water widely available in clinical settings. 15 O-water has a reputation as a gold-standard radioactive tracer for PET imaging, but supply chain problems around the substance have hindered adoption. […]
MedTrace Pharma moves forward on 15 O-water imaging tech
MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate […]